Monlunabant
A Study to Explore the PK and PD of INV-202 in Metabolic Syndrome
Inversago Pharma · Phase 1 · Completed · Enrollment 37
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| INV-202 | Metabolic Syndrome | n/r | n/r | n/r | n/r |
| Placebo | Metabolic Syndrome | n/r | n/r | n/r | n/r |